Governance Moderna, Inc.

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-14 pm EST			5-day change	1st Jan Change
34.46 ^USD	-1.96%		-27.50%	-17.12%

05:14pm	Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating	MT
01:09pm	Stocks Gain Pre-Bell Ahead of Latest PPI Report; Asia, Europe Strong	MT

Executive Committee: Moderna, Inc.

Manager

Positions heldSince

Stéphane Bancel

52 year

Chief Executive Officer

2011-02-28

Brad Miller

Chief Tech/Sci/R&D Officer

2023-01-02

Jerh Collins

Chief Tech/Sci/R&D Officer

2022-12-31

James Mock

48 year

Director of Finance/CFO

2022-09-05

Shannon Klinger

54 year

General Counsel	2021-05-31
Corporate Secretary	2021-05-31

Jacqueline Miller

Chief Tech/Sci/R&D Officer

2024-11-06

Lavina A. Talukdar

Investor Relations Contact

2019-03-31

Tracey Franklin

45 year

Chief Tech/Sci/R&D Officer	2024-11-06
Human Resources Officer	2019-10-30

Stephen Hoge

49 year

President

2015-01-31

Composition of the Board of Directors: Moderna, Inc.

Director

CommitteesSince

Noubar Afeyan

61 year

Compensation Committee Chair	2004-12-31
Nominating Committee Chair	2012-01-31
Governance Committee Chair	2012-01-31

Elizabeth Tallett

76 year

Audit Committee
Governance Committee	2018-05-15
Nominating Committee
Compensation Committee Chair	2010-12-31
HR Committee Chair	2011-05-31
Compensation Committee
HR Committee
Audit Committee Chair	2020-12-31

Elizabeth Nabel

73 year

Compensation Committee Chair
Compensation Committee
HR Committee
Audit Committee	2021-06-01
Governance Committee	2022-12-31
Nominating Committee	2022-12-31

Shah Hussain

60 year

Governance Committee	2024-02-01
Compensation Committee Chair	2024-02-01
HR Committee Chair	2024-02-01
Audit Committee	2024-10-01

Paul Sagan

66 year

Audit Committee	2020-12-31
Governance Committee	2021-01-31
Nominating Committee	2021-01-31

Francois Nader

68 year

Compensation Committee Chair
HR Committee Chair

Sandra Horning

76 year

Governance Committee	2020-02-29
Nominating Committee	2020-02-29

David Rubenstein

75 year

Audit Committee

2024-08-04

Stéphane Bancel

52 year

Director/Board Member

2011-02-28

Latest Appointments: Moderna, Inc.

Top Midday Stories: Vaccine Stocks Fall on RFK Jr. HHS Nomination; GM Plans to Cut 1,000 Salaried Workers	Nov. 15	MT
Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary	Nov. 15	MT
Bancel Steps Down as Moderna Sales Chief, Keeps CEO Post	Nov. 05	MT
Moderna's Bancel Steps Down as Sales Chief, Keeps CEO Post, Bloomberg Reports	Nov. 05	MT
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports	Nov. 05	RE
NovoCure Limited Appoints Christoph Brackmann as Senior Financial Advisor	24-10-30	CI

More news

Former Officers and Directors: Moderna, Inc.

Insider

Positions held

SinceUntil

Robert Langer

Director/Board Member	2010-11-30	2024-08-04
Founder	2009-12-31	2024-08-04
Independent Dir/Board Member	2010-11-30	2024-08-04

Stephen Berenson

Director/Board Member	2017-09-30	2024-08-04
Independent Dir/Board Member	2017-09-30	2024-08-04

Arpa Garay

Corporate Officer/Principal

2022-05-30

2023-12-07

Ronald Filippo

Corporate Officer/Principal

2021-08-31

2023-10-31

Juan Andres

Chief Tech/Sci/R&D Officer	2017-07-31	2022-12-31
Corporate Officer/Principal	2022-12-31	2023-05-30

Paul Burton

Chief Tech/Sci/R&D Officer

2021-07-05

2022-12-31

Stephanie Engels

Corporate Officer/Principal

2020-06-30

2022-10-31

Jorge Gomez

Director of Finance/CFO

2022-05-08

2022-05-09

David Meline

Director of Finance/CFO	2020-06-07	2022-05-08
Director of Finance/CFO	2022-05-09	2022-09-05

Marcello Damiani

Corporate Officer/Principal

2018-08-31

2021-12-31

Corinne Le Goff

Corporate Officer/Principal

2021-01-18

2021-12-31

Tal Zaks

Chief Tech/Sci/R&D Officer

2015-02-28

2021-07-05

Lori M. Henderson

General Counsel	2018-03-31	2021-05-31
Corporate Secretary	2018-03-31	2021-05-31

Raymond C. Jordan

Corporate Officer/Principal

2020-06-14

Lorence Kim

Director of Finance/CFO	2014-03-31	2020-06-07
Investor Relations Contact	2014-03-31	2020-06-07

Moncef Slaoui

Director/Board Member	2017-06-30	2020-05-14
Independent Dir/Board Member	2017-06-30	2020-05-14

Jennifer Ling Lee

Comptroller/Controller/Auditor

2020-01-01

Megan E. Pace

Corporate Officer/Principal

2018-03-31

2019-12-31

Peter Hutt

Director/Board Member	2012-02-29	2019-12-08
Independent Dir/Board Member	2012-02-29	2019-12-08

Colleen Hussey

Public Communications Contact

2019-07-31

Robert Dolski

Corporate Officer/Principal

2016-05-31

2019-04-30

Anne Drapeau

Human Resources Officer

2016-09-30

2019-04-30

Stephen Harbin

Corporate Officer/Principal

2017-07-31

2019-03-31

Christoph Brackmann

Corporate Officer/Principal

2018-12-31

Theodore Ashburn

Corporate Officer/Principal

2017-08-31

2018-06-30

Richard J. Wanstall

Director of Finance/CFO

2014-06-30

2018-06-30

Giuseppe Ciaramella

Chief Tech/Sci/R&D Officer

2013-12-31

2018-01-31

Lee Cooper

Corporate Officer/Principal

2015-05-31

2017-12-30

Jason Glashow

Public Communications Contact

2017-11-30

Wendy Arnold

Human Resources Officer

2013-12-31

2017-11-30

Matthew Stanton

Corporate Officer/Principal

2014-03-31

2017-08-31

Barry Ticho

Corporate Officer/Principal

2016-01-31

2017-08-31

Saqib Islam

Corporate Officer/Principal

2016-01-31

2017-07-31

Henri A. Termeer

Director/Board Member

2017-05-11

Jim Kasinger

General Counsel	2014-03-31	2017-04-30
Corporate Secretary	2014-03-31	2017-04-30

Israel Ruiz

Director/Board Member	2017-01-31	-
Independent Dir/Board Member	2017-01-31	-

Francine Gregoire

Corporate Officer/Principal

2013-10-31

2016-02-29

Theo Melas-Kyriazi

Director/Board Member

2013-12-31

2015-12-31

Paula Soteropoulos

Corporate Officer/Principal

2013-06-30

2014-11-30

Louis St. Laurence O'Dea

Chief Tech/Sci/R&D Officer

2011-12-31

2014-05-31

John Mendlein

Director/Board Member	2019-01-31	-
Corporate Officer/Principal	2018-01-30	2019-01-31

Kenneth R. Chien

Founder

2009-12-31

Derrick J. Rossi

Founder

2009-12-31

Joe Bolen

Chief Tech/Sci/R&D Officer	-	-
President	-	-

Axel Bouchon

Corporate Officer/Principal

Kate Beresford O'Malley

Public Communications Contact

Gregory Licholai

Corporate Officer/Principal

Leiden Dworak

Director/Board Member

Christine Swenson

General Counsel

Douglas Cole

Director/Board Member	-	-
Founder	-	-

Scott Sudduth

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	21
Female	4

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	8
Female	1

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (97.4%); - grant revenue (1.4%); - revenue from collaboration agreements (1.2%). At the end of 2023, the group possessed a portfolio of 41 products in clinical development, of which 6 in phase III, 12 in phase II and 18 in phase I, and 5 products in preclinical development. Net sales are distributed geographically as follows: the United States (27.7%), Europe (19.8%) and other (52.5%).

Employees

5,600

Sector

Biotechnology & Medical Research

Calendar

06:45pm - JP Morgan Healthcare Conference

More about the company

Governance Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Executive Committee: Moderna, Inc.

Composition of the Board of Directors: Moderna, Inc.

Latest Appointments: Moderna, Inc.

Former Officers and Directors: Moderna, Inc.

Age distribution of managers

Parity Men Women

ESG

Company Profile